PDB Short entry for 1V7P HEADER TOXIN/CELL ADHESION 19-DEC-03 1V7P TITLE STRUCTURE OF EMS16-ALPHA2-I DOMAIN COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: EMS16 A CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1-134; COMPND 5 SYNONYM: EMS16 SUBUNIT A; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: EMS16 B CHAIN; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: RESIDUES 1-128; COMPND 10 SYNONYM: EMS16 SUBUNIT B; COMPND 11 MUTATION: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: INTEGRIN ALPHA-2; COMPND 14 CHAIN: C; COMPND 15 FRAGMENT: RESIDUES 138-337; COMPND 16 SYNONYM: ALPHA2-I, PLATELET MEMBRANE GLYCOPROTEIN IA, GPIA, COLLAGEN COMPND 17 RECEPTOR, VLA-2 ALPHA CHAIN, CD49B; COMPND 18 ENGINEERED: YES; COMPND 19 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ECHIS MULTISQUAMATUS; SOURCE 3 ORGANISM_TAXID: 93050; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: ECHIS MULTISQUAMATUS; SOURCE 6 ORGANISM_TAXID: 93050; SOURCE 7 MOL_ID: 3; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 12 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 13 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_VECTOR_TYPE: PLAMID; SOURCE 15 EXPRESSION_SYSTEM_PLASMID: PET32A KEYWDS SNAKE VENOM, C-TYPE LECTIN, ANTAGONIST, INTEGRIN, CELL ADHESION, KEYWDS 2 GLYCOPROTEIN, TOXIN-CELL ADHESION COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.HORII,D.OKUDA,T.MORITA,H.MIZUNO REVDAT 5 10-NOV-21 1V7P 1 SEQADV HETSYN REVDAT 4 29-JUL-20 1V7P 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 13-JUL-11 1V7P 1 VERSN REVDAT 2 24-FEB-09 1V7P 1 VERSN REVDAT 1 07-SEP-04 1V7P 0 JRNL AUTH K.HORII,D.OKUDA,T.MORITA,H.MIZUNO JRNL TITL CRYSTAL STRUCTURE OF EMS16 IN COMPLEX WITH THE INTEGRIN JRNL TITL 2 ALPHA2-I DOMAIN JRNL REF J.MOL.BIOL. V. 341 519 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15276841 JRNL DOI 10.1016/J.JMB.2004.06.036 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.HORII,D.OKUDA,T.MORITA,H.MIZUNO REMARK 1 TITL STRUCTURAL CHARCTERIZATION OF EMS16, AN ANTAGONIST OF REMARK 1 TITL 2 COLLAGEN RECEPTOR (GPIA/IIA) FROM THE VENOM OF ECHIS REMARK 1 TITL 3 MULTISQUAMATUS REMARK 1 REF BIOCHEMISTRY V. 42 12497 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 14580195 REMARK 1 DOI 10.1021/BI034890H REMARK 1 REFERENCE 2 REMARK 1 AUTH J.EMSLEY,S.L.KING,J.M.BERGELSON,R.C.LIDDINGTON REMARK 1 TITL CRYSTAL STRUCTURE OF THE I DOMAIN FROM INTEGRIN ALPHA2BETA1 REMARK 1 REF J.BIOL.CHEM. V. 272 28512 1997 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 9353312 REMARK 1 DOI 10.1074/JBC.272.45.28512 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.EMSLEY,C.G.KNIGHT,R.W.FARNDALE,M.J.BARNES,R.C.LIDDINGTON REMARK 1 TITL STRUCTURAL BASIS OF COLLAGEN RECOGNITION BY INTEGRIN REMARK 1 TITL 2 ALPHA2BETA1 REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 101 47 2000 REMARK 1 REFN ISSN 0092-8674 REMARK 1 PMID 10778855 REMARK 1 DOI 10.1016/S0092-8674(00)80622-4 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1880292.300 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 33892 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1693 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5028 REMARK 3 BIN R VALUE (WORKING SET) : 0.2170 REMARK 3 BIN FREE R VALUE : 0.2600 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 279 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3669 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 21 REMARK 3 SOLVENT ATOMS : 463 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.72000 REMARK 3 B22 (A**2) : 11.41000 REMARK 3 B33 (A**2) : -4.69000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.65000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.13 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.710 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.340 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.970 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.130 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.150 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 38.71 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1V7P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-DEC-03. REMARK 100 THE DEPOSITION ID IS D_1000006310. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUN-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : AR-NW12A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33974 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 19.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.20900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8000, POTASSIUM DIHYDROGEN REMARK 280 PHOSPHATE, SODIUM CHLORIDE, MALONIC ACID, MANGANESE CHLORIDE, PH REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 81.88300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.22450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 81.88300 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.22450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C1509 LIES ON A SPECIAL POSITION. REMARK 375 HOH C1528 LIES ON A SPECIAL POSITION. REMARK 375 HOH C1543 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL B 128 REMARK 465 GLY C 138 REMARK 465 SER C 139 REMARK 465 SER C 140 REMARK 465 PRO C 141 REMARK 465 SER C 142 REMARK 465 GLU C 336 REMARK 465 GLY C 337 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 3 -10.62 68.79 REMARK 500 ASP A 7 -21.95 84.74 REMARK 500 ASP A 12 -141.45 52.89 REMARK 500 GLN A 13 20.23 -74.06 REMARK 500 ILE A 92 -67.81 -130.78 REMARK 500 ASN A 95 59.12 -143.24 REMARK 500 ASN B 69 83.35 60.78 REMARK 500 LYS C 179 -118.93 -125.71 REMARK 500 ALA C 188 -105.75 -161.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN C1500 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER C 153 OG REMARK 620 2 SER C 155 OG 95.1 REMARK 620 3 ASP C 254 OD2 95.8 82.9 REMARK 620 4 HOH C1501 O 85.2 161.9 79.1 REMARK 620 5 HOH C1502 O 85.0 88.5 171.3 109.5 REMARK 620 6 HOH C1503 O 170.9 89.2 92.6 93.2 87.2 REMARK 620 N 1 2 3 4 5 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UKM RELATED DB: PDB REMARK 900 UNCOMPLEXED EMS16 REMARK 900 RELATED ID: 1AOX RELATED DB: PDB REMARK 900 UNCOMPLEXED ALPHA2-I DOMAIN REMARK 900 RELATED ID: 1DZI RELATED DB: PDB REMARK 900 ALPHA2-I DOMAIN IN COMPLEX WITH COLLAGEN LIKE PEPTIDE DBREF 1V7P A 1 134 UNP Q7T2Q1 Q7T2Q1_ECHML 24 157 DBREF 1V7P B 1 128 UNP Q7T2Q0 Q7T2Q0_ECHML 27 154 DBREF 1V7P C 138 337 UNP P17301 ITA2_HUMAN 167 366 SEQADV 1V7P SER B 43 UNP Q7T2Q0 GLY 69 ENGINEERED MUTATION SEQADV 1V7P GLY C 138 UNP P17301 GLN 167 ENGINEERED MUTATION SEQADV 1V7P SER C 139 UNP P17301 PRO 168 ENGINEERED MUTATION SEQADV 1V7P SER C 140 UNP P17301 CYS 169 ENGINEERED MUTATION SEQRES 1 A 134 ASP PHE ASP CYS PRO SER ASP TRP THR ALA TYR ASP GLN SEQRES 2 A 134 HIS CYS TYR LEU ALA ILE GLY GLU PRO GLN ASN TRP TYR SEQRES 3 A 134 GLU ALA GLU ARG PHE CYS THR GLU GLN ALA LYS ASP GLY SEQRES 4 A 134 HIS LEU VAL SER ILE GLN SER ARG GLU GLU GLY ASN PHE SEQRES 5 A 134 VAL ALA GLN LEU VAL SER GLY PHE MET HIS ARG SER GLU SEQRES 6 A 134 ILE TYR VAL TRP ILE GLY LEU ARG ASP ARG ARG GLU GLU SEQRES 7 A 134 GLN GLN CYS ASN PRO GLU TRP ASN ASP GLY SER LYS ILE SEQRES 8 A 134 ILE TYR VAL ASN TRP LYS GLU GLY GLU SER LYS MET CYS SEQRES 9 A 134 GLN GLY LEU THR LYS TRP THR ASN PHE HIS ASP TRP ASN SEQRES 10 A 134 ASN ILE ASN CYS GLU ASP LEU TYR PRO PHE VAL CYS LYS SEQRES 11 A 134 PHE SER ALA VAL SEQRES 1 B 128 CYS PRO LEU GLY TRP SER SER PHE ASP GLN HIS CYS TYR SEQRES 2 B 128 LYS VAL PHE GLU PRO VAL LYS ASN TRP THR GLU ALA GLU SEQRES 3 B 128 GLU ILE CYS MET GLN GLN HIS LYS GLY SER ARG LEU ALA SEQRES 4 B 128 SER ILE HIS SER SER GLU GLU GLU ALA PHE VAL SER LYS SEQRES 5 B 128 LEU ALA SER LYS ALA LEU LYS PHE THR SER MET TRP ILE SEQRES 6 B 128 GLY LEU ASN ASN PRO TRP LYS ASP CYS LYS TRP GLU TRP SEQRES 7 B 128 SER ASP ASN ALA ARG PHE ASP TYR LYS ALA TRP LYS ARG SEQRES 8 B 128 ARG PRO TYR CYS THR VAL MET VAL VAL LYS PRO ASP ARG SEQRES 9 B 128 ILE PHE TRP PHE THR ARG GLY CYS GLU LYS SER VAL SER SEQRES 10 B 128 PHE VAL CYS LYS PHE LEU THR ASP PRO ALA VAL SEQRES 1 C 200 GLY SER SER PRO SER LEU ILE ASP VAL VAL VAL VAL CYS SEQRES 2 C 200 ASP GLU SER ASN SER ILE TYR PRO TRP ASP ALA VAL LYS SEQRES 3 C 200 ASN PHE LEU GLU LYS PHE VAL GLN GLY LEU ASP ILE GLY SEQRES 4 C 200 PRO THR LYS THR GLN VAL GLY LEU ILE GLN TYR ALA ASN SEQRES 5 C 200 ASN PRO ARG VAL VAL PHE ASN LEU ASN THR TYR LYS THR SEQRES 6 C 200 LYS GLU GLU MET ILE VAL ALA THR SER GLN THR SER GLN SEQRES 7 C 200 TYR GLY GLY ASP LEU THR ASN THR PHE GLY ALA ILE GLN SEQRES 8 C 200 TYR ALA ARG LYS TYR ALA TYR SER ALA ALA SER GLY GLY SEQRES 9 C 200 ARG ARG SER ALA THR LYS VAL MET VAL VAL VAL THR ASP SEQRES 10 C 200 GLY GLU SER HIS ASP GLY SER MET LEU LYS ALA VAL ILE SEQRES 11 C 200 ASP GLN CYS ASN HIS ASP ASN ILE LEU ARG PHE GLY ILE SEQRES 12 C 200 ALA VAL LEU GLY TYR LEU ASN ARG ASN ALA LEU ASP THR SEQRES 13 C 200 LYS ASN LEU ILE LYS GLU ILE LYS ALA ILE ALA SER ILE SEQRES 14 C 200 PRO THR GLU ARG TYR PHE PHE ASN VAL SER ASP GLU ALA SEQRES 15 C 200 ALA LEU LEU GLU LYS ALA GLY THR LEU GLY GLU GLN ILE SEQRES 16 C 200 PHE SER ILE GLU GLY MODRES 1V7P ASN B 21 ASN GLYCOSYLATION SITE HET PO4 A1501 5 HET CL A1502 1 HET NAG B1022 14 HET MN C1500 1 HETNAM PO4 PHOSPHATE ION HETNAM CL CHLORIDE ION HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MN MANGANESE (II) ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 PO4 O4 P 3- FORMUL 5 CL CL 1- FORMUL 6 NAG C8 H15 N O6 FORMUL 7 MN MN 2+ FORMUL 8 HOH *463(H2 O) HELIX 1 1 ASN A 24 ALA A 36 1 13 HELIX 2 2 SER A 46 VAL A 57 1 12 HELIX 3 3 SER A 58 ARG A 63 5 6 HELIX 4 4 TRP A 110 ASN A 112 5 3 HELIX 5 5 ASN B 21 HIS B 33 1 13 HELIX 6 6 SER B 43 LEU B 58 1 16 HELIX 7 7 PRO C 158 GLY C 172 1 15 HELIX 8 8 THR C 202 THR C 213 1 12 HELIX 9 9 ASN C 222 ALA C 234 1 13 HELIX 10 10 SER C 236 GLY C 240 5 5 HELIX 11 11 ASP C 259 SER C 261 5 3 HELIX 12 12 MET C 262 ASP C 273 1 12 HELIX 13 13 LEU C 283 ASN C 289 1 7 HELIX 14 14 THR C 293 ALA C 304 1 12 HELIX 15 15 PRO C 307 TYR C 311 1 5 HELIX 16 16 GLU C 318 GLU C 323 5 6 HELIX 17 17 LYS C 324 SER C 334 1 11 SHEET 1 A 4 THR A 9 TYR A 11 0 SHEET 2 A 4 HIS A 14 GLN A 23 -1 O TYR A 16 N THR A 9 SHEET 3 A 4 TYR A 125 SER A 132 -1 O PHE A 127 N ILE A 19 SHEET 4 A 4 HIS A 40 LEU A 41 -1 N HIS A 40 O LYS A 130 SHEET 1 B 4 TRP A 116 ILE A 119 0 SHEET 2 B 4 CYS A 104 THR A 108 -1 N CYS A 104 O ILE A 119 SHEET 3 B 4 TYR A 67 ARG A 73 -1 N VAL A 68 O LEU A 107 SHEET 4 B 4 GLU B 77 TRP B 78 -1 O GLU B 77 N ARG A 73 SHEET 1 C 4 SER B 6 PHE B 8 0 SHEET 2 C 4 HIS B 11 LYS B 20 -1 O TYR B 13 N SER B 6 SHEET 3 C 4 VAL B 116 LEU B 123 -1 O PHE B 118 N PHE B 16 SHEET 4 C 4 ARG B 37 LEU B 38 -1 N ARG B 37 O LYS B 121 SHEET 1 D 6 SER B 6 PHE B 8 0 SHEET 2 D 6 HIS B 11 LYS B 20 -1 O TYR B 13 N SER B 6 SHEET 3 D 6 VAL B 116 LEU B 123 -1 O PHE B 118 N PHE B 16 SHEET 4 D 6 SER B 62 ASN B 68 1 N TRP B 64 O SER B 117 SHEET 5 D 6 TYR B 94 VAL B 100 -1 O MET B 98 N MET B 63 SHEET 6 D 6 ILE B 105 GLY B 111 -1 O ARG B 110 N CYS B 95 SHEET 1 E 6 PRO C 191 PHE C 195 0 SHEET 2 E 6 THR C 180 TYR C 187 -1 N LEU C 184 O VAL C 194 SHEET 3 E 6 ILE C 144 ASP C 151 1 N VAL C 146 O GLN C 181 SHEET 4 E 6 THR C 246 THR C 253 1 O VAL C 250 N VAL C 149 SHEET 5 E 6 ILE C 275 VAL C 282 1 O ILE C 280 N VAL C 251 SHEET 6 E 6 PHE C 312 VAL C 315 1 O PHE C 313 N GLY C 279 SSBOND 1 CYS A 4 CYS A 15 1555 1555 2.03 SSBOND 2 CYS A 32 CYS A 129 1555 1555 2.03 SSBOND 3 CYS A 81 CYS B 74 1555 1555 2.03 SSBOND 4 CYS A 104 CYS A 121 1555 1555 2.04 SSBOND 5 CYS B 1 CYS B 12 1555 1555 2.03 SSBOND 6 CYS B 29 CYS B 120 1555 1555 2.03 SSBOND 7 CYS B 95 CYS B 112 1555 1555 2.04 LINK ND2 ASN B 21 C1 NAG B1022 1555 1555 1.45 LINK OG SER C 153 MN MN C1500 1555 1555 2.36 LINK OG SER C 155 MN MN C1500 1555 1555 2.13 LINK OD2 ASP C 254 MN MN C1500 1555 1555 2.21 LINK MN MN C1500 O HOH C1501 1555 1555 2.15 LINK MN MN C1500 O HOH C1502 1555 1555 2.51 LINK MN MN C1500 O HOH C1503 1555 1555 2.66 CISPEP 1 TYR C 157 PRO C 158 0 -0.13 CISPEP 2 ILE C 306 PRO C 307 0 0.33 CRYST1 163.766 38.449 69.524 90.00 91.52 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006106 0.000000 0.000162 0.00000 SCALE2 0.000000 0.026008 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014389 0.00000